Dr. Lixia Zhao Ellis, M.D., PH.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Dr, Bennington, VT 05201 Phone: 802-447-5544 |
Alan Neal Binnick, MD Dermatology - Dermatopathology Medicare: Not Enrolled in Medicare Practice Location: 140 Hospital Dr, Suite 109, Bennington, VT 05201 Phone: 802-447-7441 Fax: 802-447-0254 |
News Archive
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the contract signing for a Phase IV, eight-year, 500-site, 5,000-patient study worth approximately $900,000 with a global specialty pharmaceutical and medication delivery company.
A new predictive marker which could help doctors to decide whether breast cancer patients would benefit from chemotherapy has been identified by a team of scientists.The study, part-funded by Cancer Research UK and published in the British Journal of Cancer today (Wednesday), shows for the first time how this molecular marker has been singled out as an independent factor in examining a breast cancer patient's tumour.
Inpatients cared for by hospitalists have higher Medicare costs in the 30 days after discharge than those whose personal physicians oversee their care. This is partly because hospitalists' patients are more likely to be discharged to a rehabilitation or nursing facility than to their homes and more likely to have subsequent emergency room visits and readmissions.
There is merit in looking at the use of wearable biosensors to detect whether opioid users stay focused on their rehabilitation programs.
A University of Colorado Cancer Center study published in the journal PLoS One finds alterations in expression of genes PIK3R3 and PTEN, more commonly observed in adult tumors, in the rare, young-adult bone cancer Ewing Sarcoma, potentially offering ways to improve therapy.
› Verified 1 days ago